Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -232.60% | 89.54% | -39.62% | 35.45% | -32.21% |
| Total Depreciation and Amortization | 3.31% | -11.91% | -4.60% | 0.37% | 3.19% |
| Total Amortization of Deferred Charges | -- | -- | 1.00% | -- | -- |
| Total Other Non-Cash Items | -25.13% | -69.52% | 267.85% | -180.10% | 8,156.77% |
| Change in Net Operating Assets | 84.10% | 70.02% | -503.51% | 321.63% | -79.20% |
| Cash from Operations | -53.93% | 138.06% | -50.28% | -47.59% | -9.32% |
| Capital Expenditure | 91.66% | -109.89% | 27.75% | -1.81% | 36.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 98.06% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.66% | -109.89% | 27.75% | 9.58% | 86.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -372.90% | -6,401.27% | 49.36% | -14.71% | 0.00% |
| Issuance of Common Stock | -- | -- | 4,051.35% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.76% | 31.38% | 17.15% | -249.61% | 228.39% |
| Cash from Financing | -79.23% | -2,941.08% | 77.99% | -437.74% | 68.69% |
| Foreign Exchange rate Adjustments | -43.33% | 114.29% | 275.00% | 92.79% | -252.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.06% | -91.01% | -1.33% | -73.86% | 59.44% |